SwedenLivingWorldBusinessSportsEntertainment
Cover image for Per Hansen
Per Hansen

Per Hansen

Billion-dollar decline expected in Novo Nordisk profits
Business News

Billion-dollar decline expected in Novo Nordisk profits

Danish pharmaceutical company Novo Nordisk's results are affecting the entire nation's economy. The quarterly report will be released tomorrow - and profits are expected to fall by billions
Patent expires - Ozempic price may be pressured
Business NewsTop News

Patent expires - Ozempic price may be pressured

After a turbulent year, new challenges await pharmaceutical giant Novo Nordisk. Competitors are poised to capitalize as the patent on its best-selling drug expires in several markets
Novo Nordisk exceeds expectations: "Outstanding"
Business News

Novo Nordisk exceeds expectations: "Outstanding"

The Danish pharmaceutical giant Novo Nordisk, known for the weight loss preparations Ozempic and Wegovy, reports a full-year sales figure that beats market expectations. It's a really good ending to a turbulent year, says Per Hansen, investment economist at Nordnet in Denmark
The Shock in Denmark: "Completely Crazy"
Business News

The Shock in Denmark: "Completely Crazy"

The crash in the Novo Nordisk share is "completely crazy", believes Per Hansen, investment economist at Nordnet in Denmark. It has a huge significance for investors, but also for the Danish economy as a whole, he says
Show Consent Options

Categories

Information

Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald